What contributes to quality of life in patients with Parkinson's disease?

A Schrag, M Jahanshahi, N Quinn, A Schrag, M Jahanshahi, N Quinn

Abstract

Objective: To identify the factors that determine quality of life (QoL) in patients with idiopathic Parkinson's disease in a population based sample. Quality of life (QoL) is increasingly recognised as a critical measure in health care as it incorporates the patients' own perspective of their health.

Methods: All patients with Parkinson's disease seen in a population based study on the prevalence of parkinsonism were asked to complete a disease-specific QoL questionnaire (PDQ-39) and the Beck depression inventory. A structured questionnaire interview and a complete neurological examination, including the Hoehn and Yahr scale, the Schwab and England disability scale, the motor part of the unified Parkinson's disease rating scale (UPDRS part III), and the mini mental state examination were performed by a neurologist on the same day.

Results: The response rate was 78%. The factor most closely associated with QoL was the presence of depression, but disability, as measured by the Schwab and England scale, postural instability, and cognitive impairment additionally contributed to poor QoL. Although the UPDRS part III correlated significantly with QoL scores, it did not contribute substantially to predicting their variance once depression, disability, and postural instability had been taken into account. In addition, patients with akinetic rigid Parkinson's disease had worse QoL scores than those with tremor dominant disease, mainly due to impairment of axial features.

Conclusion: Depression, disability, postural instability, and cognitive impairment have the greatest influence on QoL in Parkinson's disease. The improvement of these features should therefore become an important target in the treatment of the disease.

References

    1. Neurology. 1999 Nov 10;53(8):1839-43
    1. Arch Gen Psychiatry. 1961 Jun;4:561-71
    1. Lancet. 1999 Nov 20;354(9192):1771-5
    1. Neurology. 1967 May;17(5):427-42
    1. J Psychiatr Res. 1975 Nov;12(3):189-98
    1. Neurology. 1985 Apr;35(4):522-6
    1. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
    1. Psychol Med. 1988 Nov;18(4):925-33
    1. Neurology. 1990 Oct;40(10):1529-34
    1. Med Care. 1993 Mar;31(3):247-63
    1. Neurology. 1993 Nov;43(11):2227-9
    1. Mov Disord. 1994 May;9(3):340-2
    1. Qual Life Res. 1995 Jun;4(3):241-8
    1. Stroke. 1996 Sep;27(9):1467-72
    1. Qual Life Res. 1996 Apr;5(2):195-204
    1. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):104
    1. Eur Neurol. 1997;37(1):23-7
    1. Age Ageing. 1997 Sep;26(5):353-7
    1. Mov Disord. 1997 Nov;12(6):916-22
    1. J Affect Disord. 1997 Dec;46(3):255-62
    1. J Neurol. 1998 May;245 Suppl 1:S10-4
    1. N Engl J Med. 1998 Oct 15;339(16):1130-43
    1. J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):431-5

Source: PubMed

3
Subscribe